Mithra Pharmaceuticals SA MITRA-BE:Euronext Brussels

*Data is delayed | EUR
Last | 10:24 AM CET
20.15quote price arrow down-0.15 (-0.74%)
Volume
5,446
52 week range
13.09 - 24.90

...

Loading . . .

KEY STATS

  • Open20.45
  • Day High20.50
  • Day Low20.15
  • Prev Close20.30
  • 52 Week High24.90
  • 52 Week High Date03/03/20
  • 52 Week Low13.09
  • 52 Week Low Date03/16/20
  • Market Cap1,062.57M
  • Shares Out42.55M
  • 10 Day Average Volume36,119.3
  • Dividend-
  • Dividend Yield-
  • Beta1.21
  • 1 Year % Change-15.34

RATIOS/PROFITABILITY

  • EPS (TTM)0.87
  • P/E (TTM)23.25
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Mithra Pharmaceuticals SA News

There is no recent news for this security.

Latest MITRA-BE News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Mithra Pharmaceuticals SA is a Belgian-based company active in the pharmaceutical industry. The Company is a biotech company providing solutions in a field of women’s health, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. The Company provides three development candidates built on Mithra’s estrogen platform, Estetrol (E4): Estelle, a...
Marc Coucke
Non-Executive Chairman
Leon Van Rompay
Chief Executive Officer
Christophe Marechal
Chief Financial Officer
Jean-Manuel Fontaine
Vice President
Address
Rue Saint-Georges 5
Liege
4000
Belgium